By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Delcath Systems, Inc. 

1100 Summer Street, 3rd Floor

Stamford  Connecticut  06905  U.S.A.
Phone: 203-323-8668 Fax: 203-961-0120


Drug Delivery

Company News
Delcath Systems (DCTH) Announces First Quarter Financial Results 5/4/2016 7:27:51 AM
Leading U.S. Cancer Centers Join Delcath Systems (DCTH)'s Focus Phase 3 Trial For Patients With Hepatic Dominant Ocular Melanoma 5/3/2016 6:52:21 AM
Delcath Systems (DCTH) Announces First CHEMOSAT Procedures In Turkey 4/8/2016 7:22:34 AM
Delcath Systems (DCTH) Announces 2015 Fourth Quarter And Full Year Financial Results 3/21/2016 7:12:04 AM
Delcath Systems (DCTH) To Present At The 28th Annual ROTH Conference 3/7/2016 7:54:05 AM
Delcath Systems (DCTH) Announces Engagement Of Lars E. Birgerson, M.D., Ph. D As Global Medical Consultant 2/11/2016 6:56:01 AM
Delcath Systems (DCTH) Announces Beginning Of Patient Enrollment In Phase 3 Focus Trial 2/10/2016 6:45:19 AM
Delcath Systems (DCTH) To Present At Upcoming Investor Conferences 2/4/2016 8:30:30 AM
Delcath Systems (DCTH) Announces Initiation Of Phase 3 Trial Of Melphalan/Hds System For Treatment Of Hepatic Dominant Ocular Melanoma 1/20/2016 6:13:14 AM
Delcath Systems (DCTH) Announces Special Protocol Assessment Agreement With FDA For New Phase 3 Trial In Hepatic Dominant Ocular Melanoma 1/19/2016 6:18:26 AM